These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 38113000)
1. Recent Advances in RNA m Verghese M; Wilkinson E; He YY Cancer Treat Res; 2023; 190():95-142. PubMed ID: 38113000 [TBL] [Abstract][Full Text] [Related]
2. Roles and implications of mRNA N Zeng L; Huang X; Zhang J; Lin D; Zheng J Cancer Commun (Lond); 2023 Jul; 43(7):729-748. PubMed ID: 37350762 [TBL] [Abstract][Full Text] [Related]
4. Emerging Roles of N6-Methyladenosine (m6A) Epitranscriptomics in Toxicology. Malovic E; Ealy A; Kanthasamy A; Kanthasamy AG Toxicol Sci; 2021 Apr; 181(1):13-22. PubMed ID: 33616673 [TBL] [Abstract][Full Text] [Related]
5. Epitranscriptomics: regulation of mRNA metabolism through modifications. Peer E; Rechavi G; Dominissini D Curr Opin Chem Biol; 2017 Dec; 41():93-98. PubMed ID: 29125941 [TBL] [Abstract][Full Text] [Related]
6. RNA m Wang Z; Zhou J; Zhang H; Ge L; Li J; Wang H Mol Oncol; 2023 Feb; 17(2):195-229. PubMed ID: 36260366 [TBL] [Abstract][Full Text] [Related]
7. The role of mRNA m Li J; Yang X; Qi Z; Sang Y; Liu Y; Xu B; Liu W; Xu Z; Deng Y Cell Biosci; 2019; 9():66. PubMed ID: 31452869 [TBL] [Abstract][Full Text] [Related]
8. The role of RNA methylation in tumor immunity and its potential in immunotherapy. Li Y; Jin H; Li Q; Shi L; Mao Y; Zhao L Mol Cancer; 2024 Jun; 23(1):130. PubMed ID: 38902779 [TBL] [Abstract][Full Text] [Related]
9. RNA N6-methyladenosine methylation and skin diseases. Yu Y; Lu S; Jin H; Zhu H; Wei X; Zhou T; Zhao M Autoimmunity; 2023 Dec; 56(1):2167983. PubMed ID: 36708146 [TBL] [Abstract][Full Text] [Related]
10. N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases. Maity A; Das B FEBS J; 2016 May; 283(9):1607-30. PubMed ID: 26645578 [TBL] [Abstract][Full Text] [Related]
11. Advances in targeting RNA modifications for anticancer therapy. Pomaville MM; He C Trends Cancer; 2023 Jul; 9(7):528-542. PubMed ID: 37147166 [TBL] [Abstract][Full Text] [Related]
12. N Dong S; Wu Y; Liu Y; Weng H; Huang H Cancer Commun (Lond); 2021 Jul; 41(7):538-559. PubMed ID: 33955720 [TBL] [Abstract][Full Text] [Related]
13. Functions of N6-methyladenosine and its role in cancer. He L; Li H; Wu A; Peng Y; Shu G; Yin G Mol Cancer; 2019 Dec; 18(1):176. PubMed ID: 31801551 [TBL] [Abstract][Full Text] [Related]
14. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy. Guo L; Yang H; Zhou C; Shi Y; Huang L; Zhang J Front Immunol; 2021; 12():773570. PubMed ID: 34956201 [TBL] [Abstract][Full Text] [Related]
15. m Yang D; Zhao G; Zhang HM Front Cell Infect Microbiol; 2023; 13():1151069. PubMed ID: 37325513 [TBL] [Abstract][Full Text] [Related]
16. Epitranscriptomic(N6-methyladenosine) Modification of Viral RNA and Virus-Host Interactions. Imam H; Kim GW; Siddiqui A Front Cell Infect Microbiol; 2020; 10():584283. PubMed ID: 33330128 [TBL] [Abstract][Full Text] [Related]
17. The functions of N6-methyladenosine (m6A) RNA modifications in colorectal cancer. Qiao H; Liu L; Chen J; Shang B; Wang L Med Oncol; 2022 Sep; 39(12):235. PubMed ID: 36175777 [TBL] [Abstract][Full Text] [Related]
18. Epitranscriptomics Changes the Play: m Akçaöz A; Akgül B Adv Exp Med Biol; 2022; 1401():163-171. PubMed ID: 35781217 [TBL] [Abstract][Full Text] [Related]
19. m He PC; He C EMBO J; 2021 Feb; 40(3):e105977. PubMed ID: 33470439 [TBL] [Abstract][Full Text] [Related]